Replimune eliminates CMO role; Dr. Andrea Pirzkall terminated without cause

Replimune Group, Inc.

All Chief Medical Officer functions now report to President and Chief R&D Officer Dr. Robert Coffin or Chief Development Operations Officer Tanya Lewis.
Chief Medical Officer role eliminated effective August 25, 2021.
Dr. Andrea Pirzkall notified of termination without cause on same date.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Dr. Andrea Pirzkall

Chief Medical Officer

REPL · Replimune Group, Inc.

Effective: 2021-08-25
Filed: August 25, 2021, 7:59 PM ET

Accordingly, on August 25, 2021, the Company notified Dr. Andrea Pirzkall that her employment with the Company has terminated, without cause.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Andrea Pirzkall was terminated as Chief Medical Officer at Replimune Group, Inc..

Action: terminated
Role: Chief Medical Officer

Exact text from the filing

Accordingly, on August 25, 2021, the Company notified Dr. Andrea Pirzkall that her employment with the Company has terminated, without cause.

View on SEC.gov

Replimune Group, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-21-109335

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.